Delta-radiomics features combined with haematological index predict pathological complete response after neoadjuvant immunochemotherapy in resectable non-small cell lung cancer
Clinical Radiology · 2025
DOI: 10.1016/j.crad.2025.106906 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Radiology, 2025. Verfasst von D Xiong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, China; Department of Radiation Oncology, Shandong Cancer Hospita…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoadjuvant Therapy, Tomography, X-Ray Computed. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
AIM: This study aimed at assessing the value of enhanced computed tomography (CT)-based delta-radiomics features (Delta-RFs) and Delta-RFs combined with haematological dynamic changes in predicting pathological complete response (PCR) after neoadjuvant immunochemotherapy in non-small cell lung cancer (NSCLC). MATERIALS AND METHODS: From January 2021 to August 2023, in total, 165 patients with stage IB-IIIB NSCLC (training, n=115, validation, n=50) who received neoadjuvant immunochemotherapy before surgery, were retrospectively enrolled. Radiomic features were extracted from tumour region of interest on pretreatment and pre-operation enhanced CT images. Delta-RFs are defined as the relative net change in radiomics features between pre-neoadjuvant immunochemotherapy and pre-operation stage. The least absolute shrinkage and selection operator was used to ensure optimal feature selection to calculate the radiomics score (Rad-score) for predicting PCR. Univariate and multivariate logistic regression analyses were performed to screen the factors related to PCR and predictive models were then constructed. RESULTS: Forty percent patients showed PCR (66/165) after neoadjuvant immunochemotherapy. Nine Delta-RFs were selected as the most predictive factors for PCR. Logistic regression analysis showed that the Rad-score (OR = 8.542, 95% CI: 3.367-21.673, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, China; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academ…
- Department of Radiation Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
- Qingdao Municipal Hospital, Qingdao, Shandong, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xiong, D., Li, J., Li, L., Xu, F., Hu, T., Zhu, H., Xu, X., Sun, Y., & Yuan, S. (2025). Delta-radiomics features combined with haematological index predict pathological complete response after neoadjuvant immunochemotherapy in resectable non-small cell lung cancer. Clinical Radiology. https://doi.org/10.1016/j.crad.2025.106906
Vancouver
Xiong D, Li J, Li L, Xu F, Hu T, Zhu H, et al. Delta-radiomics features combined with haematological index predict pathological complete response after neoadjuvant immunochemotherapy in resectable non-small cell lung cancer. Clinical Radiology. 2025. doi:10.1016/j.crad.2025.106906
BibTeX
@article{Xiong2025,
author = {Xiong, D and Li, J and Li, L and Xu, F and Hu, T and Zhu, H and Xu, X and Sun, Y and Yuan, S},
title = {Delta-radiomics features combined with haematological index predict pathological complete response after neoadjuvant immunochemotherapy in resectable non-small cell lung cancer},
journal = {Clinical Radiology},
year = {2025},
doi = {10.1016/j.crad.2025.106906}
}
EUVIMED